BioNeutra Global Corporation
BGACF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $3,735 | $4,255 | $3,816 | $1,230 |
| - Cash | $795 | $354 | $469 | $1,889 |
| + Debt | $7,543 | $7,576 | $5,578 | $7,641 |
| Enterprise Value | $10,483 | $11,477 | $8,924 | $6,982 |
| Revenue | $3,050 | $2,650 | $2,458 | $2,701 |
| % Growth | 15.1% | 7.8% | -9% | – |
| Gross Profit | $841 | $820 | -$46 | $1,659 |
| % Margin | 27.6% | 30.9% | -1.9% | 61.4% |
| EBITDA | -$161 | -$345 | -$405 | $1,875 |
| % Margin | -5.3% | -13% | -16.5% | 69.4% |
| Net Income | -$412 | -$757 | -$833 | $1,392 |
| % Margin | -13.5% | -28.6% | -33.9% | 51.5% |
| EPS Diluted | -0.01 | -0.016 | -0.018 | 0.03 |
| % Growth | 38.7% | 8.9% | -159.7% | – |
| Operating Cash Flow | $33 | $274 | -$1,213 | -$292 |
| Capital Expenditures | -$13 | -$54 | $0 | -$5 |
| Free Cash Flow | $20 | $219 | -$1,213 | -$296 |